Sana Naz
Cancer has long been one of the most formidable challenges in medicine, often evading traditional treatments and returning with renewed aggression. But in recent years, a revolutionary approach has emerged—immunotherapy, and more specifically, checkpoint inhibitors. These drugs don’t attack cancer cells directly. Instead, they empower the body’s own immune system to do what it was designed to do: recognize and destroy threats.